8th Eurasian Hematology Oncology Summit
How I Treat PV in 2021: JAKi in Symptomatic Disease, Anti-Clonal Activity of PegIFN-Alpha, Phlebotomy&ASA +/- Ropeg-IFN Alpha-2b for Low-PV
By
8th Eurasian Hematology Oncology Summit
FEATURING
Dominik Wolf
By
8th Eurasian Hematology Oncology Summit
FEATURING
Dominik Wolf
Login to view comments.
Click here to Login